[HTML][HTML] Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease
Y Li, Y Xia, S Yin, F Wan, J Hu, L Kou, Y Sun… - Frontiers in …, 2021 - frontiersin.org
According to emerging studies, the excessive activation of microglia and the subsequent
release of pro-inflammatory cytokines play important roles in the pathogenesis and …
release of pro-inflammatory cytokines play important roles in the pathogenesis and …
[HTML][HTML] Role of NLRP3 inflammasome in Parkinson's disease and therapeutic considerations
LTN Nguyen, HD Nguyen, YJ Kim… - Journal of …, 2022 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disease, with two
main pathological features: misfolded α-synuclein protein accumulation and …
main pathological features: misfolded α-synuclein protein accumulation and …
[HTML][HTML] Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct α-synuclein assemblies
H Scheiblich, L Bousset, S Schwartz… - The Journal of …, 2021 - journals.aai.org
Parkinson's disease (PD) is the second most common age-related neurodegenerative
disorder and is characterized by the formation of cellular inclusions inside neurons that are …
disorder and is characterized by the formation of cellular inclusions inside neurons that are …
[HTML][HTML] p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
J Chen, K Mao, H Yu, Y Wen, H She, H Zhang… - Journal of …, 2021 - Springer
Background Parkinson's disease (PD) is characterized by degeneration of dopaminergic
neurons in the substantia nigra pars compacta (SNpc), accompanied by accumulation of α …
neurons in the substantia nigra pars compacta (SNpc), accompanied by accumulation of α …
[HTML][HTML] MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease
Y Zhou, M Lu, RH Du, C Qiao, CY Jiang… - Molecular …, 2016 - Springer
Abstract Background α-Synuclein (α-Syn), a pathological hallmark of Parkinson's disease
(PD), has been recognized to induce the production of interleukin-1β in a process that …
(PD), has been recognized to induce the production of interleukin-1β in a process that …
[HTML][HTML] NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson's disease
QQ Han, W Le - Neuroscience Bulletin, 2023 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder caused by the loss of
dopamine neurons in the substantia nigra and the formation of Lewy bodies, which are …
dopamine neurons in the substantia nigra and the formation of Lewy bodies, which are …
[HTML][HTML] Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease
AF Pike, F Longhena, G Faustini, JM Van Eik… - Journal of …, 2022 - Springer
Background Parkinson's disease (PD) is characterized by the loss of nigral dopaminergic
neurons leading to impaired striatal dopamine signaling, α-synuclein-(α-syn-) rich …
neurons leading to impaired striatal dopamine signaling, α-synuclein-(α-syn-) rich …
Role of microgliosis and NLRP3 inflammasome in Parkinson's disease pathogenesis and therapy
FM de Araújo, L Cuenca-Bermejo… - Cellular and Molecular …, 2022 - Springer
Parkinson's disease (PD) is a neurodegenerative disorder marked primarily by motor
symptoms such as rigidity, bradykinesia, postural instability and resting tremor associated …
symptoms such as rigidity, bradykinesia, postural instability and resting tremor associated …
[HTML][HTML] The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson's disease
The pathology of Parkinson's disease (PD) is characterized by α-synuclein aggregation,
microglia-mediated neuroinflammation, and dopaminergic neurodegeneration in the …
microglia-mediated neuroinflammation, and dopaminergic neurodegeneration in the …
α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia
AF Pike, T Varanita, MAC Herrebout, BC Plug, J Kole… - Glia, 2021 - Wiley Online Library
Synucleinopathies such as Parkinson's disease (PD) are hallmarked by α‐synuclein (α‐syn)
pathology and neuroinflammation. This neuroinflammation involves activated microglia with …
pathology and neuroinflammation. This neuroinflammation involves activated microglia with …
相关搜索
- parkinson's disease nlrp3 inflammasome
- α synuclein nf kappab
- α synuclein inflammasome activation
- parkinson's disease nf kappab
- α synuclein parkinson's disease
- dopamine mechanisms nlrp3 inflammasome
- nlrp3 degradation microglia activation
- mitochondrial impairment nlrp3 inflammasome
- therapeutic considerations nlrp3 inflammasome
- parkinson's disease microglia activation
- α synuclein tlr5 ligation
- dopaminergic neurons nlrp3 inflammasome
- parkinson's disease nlrp3 degradation